ASSET TRANSFER AGREEMENTAsset Transfer Agreement • November 13th, 2020 • PDL Biopharma, Inc. • Biological products, (no disgnostic substances) • New York
This ASSET TRANSFER AGREEMENT (together with all exhibits, schedules and other documents attached hereto, this “Agreement”) dated as of August 11, 2020 is made by and between DEFINED DIAGNOSTICS, LLC (F/K/A WELLSTAT DIAGNOSTICS LLC), a Delaware limited liability company (“Transferee”), and PDL BIOPHARMA, INC., a Delaware corporation (“Transferor”).
COMMERCIAL SUBLEASE AGREEMENTCommercial Sublease Agreement • November 13th, 2020 • PDL Biopharma, Inc. • Biological products, (no disgnostic substances) • Nevada
This Commercial Sublease Agreement ("Lease") is made this 5th day of November, 2020 by and between RDH Investments, LLC ("Landlord"), and PDL BioPharma, Inc. ("Tenant”).
SETTLEMENT AND MUTUAL RELEASE AGREEMENTSettlement Agreement • November 13th, 2020 • PDL Biopharma, Inc. • Biological products, (no disgnostic substances) • Maryland
This Settlement and Mutual Release Agreement (hereinafter referred to as this “Agreement”) is entered into as of August 11, 2020, by and among PDL BioPharma, Inc. (together with its successors and assigns, hereinafter referred to as “PDL”), Samuel J. Wohlstadter, Nadine H. Wohlstadter, Hyperion Catalysis International, Wellstat Vaccines, LLC, Wellstat ImmunoTherapeutics, LLC, Wellstat BioCatalysis, LLC, Wellstat AVT Investment, LLC, Wellstat Biologics Corporation, Wellstat Management Company, LLC, Wellstat Ophthalmics Corporation, Wellstat Therapeutics Corporation, Wellstat Therapeutics EU Limited, Duck Farm, Inc., Hebron Valley Farms, Inc., HVF, Inc., Hyperion Catalysis EU Limited, NHW, LLC, and SJW Properties, Inc., together with their respective successors and assigns, (hereinafter collectively referred to as the “Wellstat Parties”), and Defined Diagnostics, LLC (f/k/a Wellstat Diagnostics, LLC) (together with its successors and assigns hereinafter referred to as “Diagnostics”). PDL
